 |
 |
|||
|
|
|||
|
|
|
Upcoming Events at the San Diego Chapter Wednesday, November 15, 2006
|
| Chris Steinhardt, Chair | Tracy Wilborn, Event Coordinator |
Tel: 619-235-8550 |
Tel: 619-687-8686 |
Fax: 619-235-0176 |
Fax: 619-235-0176 |
e-mail: csteinhardt@kmob.com |
e-mail: twilborn@kmob.com |
NOTE: This presentation will qualify for MCLE credit
PANELISTS’ BIOGRAPHIES
Arabella Carey Harrington – CEO – Defense
Technology Analysts, Inc.
Carey Harrington is the founder of several start
up service firms specializing in technology transfer, technology commercialization
and market analysis. Dedicated to Homeland Security since 2001, she has provided
services to industry and academia. She founded CCATinfo in 2003 in order to
advance technologies for Homeland Security, the fastest growing industry of
the decade. Prior
to CCATinfo, Carey served as Program Administrator for the Center for the
Commercialization of Advanced Technology in San Diego and San Bernardino. Her
clients included Eli Lily/Galbreath Kite, GTE, Orincon International, numerous
Small Business Development Centers, and California Community Colleges, CSUSB
and numerous companies throughout the United States.
Providing award winning community service throughout her career, Carey has served on numerous non-profit advisory boards. She co-founded the East Kern County Hispanic Advisory Council, and served on the Kern County Technology Transfer Group. She is currently the Director of San Diego WITI Regional Network, and sits on various committees including the MIT Forum. She is an advisor for the National Institute of Health (NIH) Commercialization Assistance Program (CAPS).
Carey graduated from the University of Redlands with a BS in Business Administration. Carey attended school in Guadalajara, Mexico (ITESO School of Psychology) and Rambouillet, France, (IIDEF, French Studies). This year she completed the Global BioExecutive Program through the University of Berkeley, Haas School of Management. She enjoys deep-sea fishing; her biggest catch to date is a 520 lb blue marlin off the coast of Kona, HI in 2003. Carey is the mother of two children, Charles and Dominique, ages 24 and 22.
Paul S. Zorner,
Ph.D. - Senior Director -
Business Development, Diversa Corporation
Diversa responsibilities
focus on the business and strategic oversight of programs for producing
renewable energy from crop biomass and business oversight of Diversa’s
grant and biodefense programs. Paul also serves as Adjunct Professor of
Horticulture at North Carolina State University and is a Senior Fellow at
Clemson’s Institute for Nutraceutical Research with a focus
on military nutrition. Paul’s undergraduate degree is from Lewis
and Clark College and his Ph.D. from Colorado State University. Paul
has held scientific, development, operations and senior administrative positions
with start-up and fortune 500 companies that include The Dow Chemical Company
(Chief Scientist – Global Biotechnology Platform) , BASF Corporation
(Manager – North American Crop Protection Discovery) , Mycogen (Vice-President,
Product Development) and CellFor Corporation (Senior Vice President, Operations). Paul
is a founder and current Director of several small biotechnology companies
focused on alternative energy and production of recombinant proteins in agricultural
crops. He also serves on the Biotechnology Business Advisory Council
for the Queensland, Australia Government. Paul was named a Queensland
Champion in 2006 for his career contributions and the first American citizen
to be so honored. He is a member of the steering committee for California’s
Secure Transportation Energy Partnership (CalSTEP) and the National Resources
Defense Council. Paul is a Fellow of the Weed Science Society of America. He
is an inventor on over 30 issued US patents and serves on the board of two
K-12 science education foundations.
Robert L. Marsella – Senior Vice
President – Hollis-Eden Pharmaceuticals, Inc.
Robert
L. Marsella became Vice President of Business Development and Marketing
of Hollis-Eden in 1997, and was promoted to Senior Vice President of Business
Development and Marketing in 2004. Mr. Marsella has more than 25 years of
medical sales, marketing, and distribution experience. Prior to joining Hollis-Eden,
Mr. Marsella acted as a distributor of various cardiac related hospital products
for a number of years. In addition, he has also served as Regional Manager
for Genentech and launched Activase™, t-pa (a biopharmaceutical drug)
in the Western United States. Prior to joining Genentech, Mr. Marsella marketed
intravenous infusion pumps for Imed Corporation for four years. Mr. Marsella
began his career as a field sales representative and soon after was promoted
to regional sales manager for U.S. Surgical Corporation, Auto Suture division.
Mr. Marsella received his B.A. degree from San Diego State University.
Mike Elconin – Technology & Business
Advisor – Center For Commercialization Of Advanced
Technology (CCAT)
Michael Elconin is an investor, technology consultant and
software developer. He has served on more than 20 corporate and non-profit
boards, including six presently. He is Vice President of the San Diego Tech
Coast Angels, also a faculty business advisor for the UCSD Jacobs School
of Engineering, and Contract Manager for the Center for the Commercialization
of Advanced Technology, a DoD funded technology incubator. He was previously
founder and CEO of Software Banc, Inc, a software and consulting firm acquired
by a publicly held competitor. In an even earlier previous life, Mr. Elconin
had a career in government - he was elected to three terms in the Wisconsin
legislature, one on the Milwaukee School Board, was the Wisconsin Governor's
Chief of Staff, and served on several other public boards and commissions.
Molecular Diagnostic Services, Inc.
Molecular Diagnostic Services, Inc. (MDS) is an independent contract research organization since 1992, providing cellular and molecular biology services to pharmaceutical, biotechnology, medical device, and research institutions. MDS is prepared to serve as a non-GLP/GMP or strictly as a GLP/GMP contract resource for developed or pre-defined protocols.
On the cutting edge of technology for 1.5 decades, MDS provides expert services in the fields of cellular and molecular biology, assay development, assay validation, cell identity, paternity, mutagenesis , in vitro toxicity, in vivo toxicity , as well as quality control services.
Our fundamental mission is helping our clients to maximize the return on their R&D investments. MDS also produces customized and specialty molecular biology reagents.
